NUMBER NUMBER total NUMBER patients NUMBER patients non hodgkin lymphomas NUMBER patients stage iv hodgkins disease treated chemotherapy upper abdominal radiotherapy patients complete remission time irradiation shielding kidneys effected start treatment right lobe liver shielded dose NUMBER gy delivered january NUMBER NUMBER patients alive free disease ranging NUMBER NUMBER months mean NUMBER months patients dead disease alterations liver chemistry observed NUMBER patients clinical jaundice transient hepatomegaly changes liver chemistry NUMBER patients classical disease NUMBER patients NUMBER patients did develop complication death complications observed contribution following factors radiotherapy dose liver drugs nutritional status associated medical conditions development complications analyzed follow follow veno occlusive